EcoDrugPlus

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSHCOG00000005758
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin-6-Like

Ensembl ID : ENSHCOG00000010860
Gene Symbol: LOC109513551
2 Cross references
162 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSHCOG00000002821
Gene Symbol: LOC109519803
3 Cross references
183 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSHCOG00000018592
Gene Symbol: LOC109518529
4 Cross references
207 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSHCOG00000003904
Gene Symbol: IDH1
3 Cross references
233 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSHCOG00000011933
Gene Symbol: IDH2
3 Cross references
207 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp] Cytoplasmic-Like

Ensembl ID : ENSHCOG00000012581
Gene Symbol: LOC109512661
3 Cross references
233 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSHCOG00000016897
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSHCOG00000015875
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSHCOG00000019380
Gene Symbol: KIF11
3 Cross references
201 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSHCOG00000013812
Gene Symbol: KIF5B
4 Cross references
234 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSHCOG00000011728
Gene Symbol: KIF5B
4 Cross references
236 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).